No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Vytorin is a combination of two drugs, ezetimibe and simvastatin, used to treat high cholesterol and other lipid disorders. It is a member of the cardiovascular drug class, which includes medications used to reduce the risk of heart attack, stroke, and other cardiovascular diseases. Vytorin works by blocking the absorption of cholesterol in the intestines and reducing the production of cholesterol in the liver. It is used in combination with a healthy diet and exercise to reduce the risk of heart attack, stroke, and other cardiovascular diseases.
Vytorin is marketed by Merck & Co. and Schering-Plough Corporation, both of which are subsidiaries of Merck & Co. Other companies in the market include Pfizer, AstraZeneca, and GlaxoSmithKline. Show Less Read more
